The Department of Health and Social Care (DHSC) has issued a Serious Shortage Protocol for Lipitor® 10mg chewable tablets in response to a significant ongoing supply disruption.
This SSP will enable community pharmacists in England and Wales to supply patients with a different formulation as per the document below.
It allows Atorvastatin 10mg tablets to be supplied against prescriptions for Lipitor® 10mg chewable tablets. The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient and should refer back to the prescriber if they consider that a non-chewable atorvastatin tablets would not be appropriate for the patient.
SSP016 for Lipitor 10mg chewable tablets will be in operation from Tuesday 15th February 2022 until Friday 18th March 2022.
Please note that the SSP may be amended or revoked at any time, so contractors must ensure that the SSP is still valid before each supply.